Boston (PRWEB) December 08, 2016
David J. Dykeman, Ginger Pigott, and J. Rick Taché, shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is a founding sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011.
From 4:45 – 6:15 p.m., Dykeman, patent attorney, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group, and co-chair of the firm’s Intellectual Property (IP) Group in Boston, will moderate the Leadership Track panel discussion, “Hot Topics: M&A, IP, Financing and Products Liability Trends Impacting MedTech Companies.” Pigott, Greenberg Traurig shareholder and vice-chair of the firm’s Pharmaceutical, Medical Device & Health Care Litigation Group in Los Angeles, and Taché, patent attorney, Orange County co-managing shareholder, co-chair of the Global Patent Litigation Group, and chair of the Orange County IP & Technology Group, will serve as panelists. They will be joined by medtech leaders, Eric P. Geismar, Executive Vice President and General Counsel, Caldera Medical Group; Stewart Davis, MD, Senior Vice President, Locust Walk; and Kleanthis G. Xanthopoulos, Ph.D., Managing General Partner, Cerus DMCC, and Executive Chairman, IRRAS AB.
Specific topics include:
- M&A trends from the perspective of both acquirer and seller
- IP protection is key to a successful exit
- Financing best practices from early stage to exit
- Products liability litigation - what every medtech company needs to know
Hosted by online journal MassDevice.com, DeviceTalks is a conversation among leaders. It’s an evening for an exchange of ideas, insight, and contacts among the pioneers of the medical technology industry. Formerly known as the Big 100, this event is held annually in Boston, Orange County, Raleigh, and the Twin Cities.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 2,000 attorneys serving clients from 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is No. 1 on the 2015 Law360 Most Charitable Firms list, third largest in the U.S. on the 2016 Law360 400, Top 20 on the 2015 Am Law Global 100, and among the 2016 BTI Brand Elite. More information at: http://www.gtlaw.com.